WallStreetZenWallStreetZen

NASDAQ: CVAC
Curevac Nv Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CVAC

Based on 3 analysts offering 12 month price targets for Curevac Nv

Min Forecast
$5.00-6.72%
Avg Forecast
$6.83+27.48%
Max Forecast
$10.00+86.57%

Should I buy or sell CVAC stock?

Based on 3 analysts offering ratings for Curevac Nv.

Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 33.33%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their CVAC stock forecasts and price targets.

CVAC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-26
lockedlocked$00.00+00.00%2025-06-13
lockedlocked$00.00+00.00%2025-05-28

1 of 1

Forecast return on equity

Is CVAC forecast to generate an efficient return?

Company
N/A
Industry
252.89%
Market
145.2%

Forecast return on assets

Is CVAC forecast to generate an efficient return on assets?

Company
N/A
Industry
107.15%

CVAC earnings per share forecast

What is CVAC's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.52-150.3%
Avg 2 year Forecast
-$0.50-148.64%
Avg 3 year Forecast
-$0.10-109.46%

CVAC revenue forecast

What is CVAC's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$60.7M-89.89%
Avg 2 year Forecast
$74.9M-87.52%
Avg 3 year Forecast
$151.5M-74.77%
CVAC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CVAC revenue growth forecast

How is CVAC forecast to perform vs Biotechnology companies and vs the US market?

Company
-38.45%
Industry
107.72%
Market
25.08%
CVAC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CVAC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CVAC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CVAC$5.36$6.83+27.48%Hold
PGEN$4.05$7.50+85.19%Buy
ARDX$5.01$11.00+119.56%Buy
PHVS$22.24$38.20+71.76%Buy
ATAI$5.78$14.00+142.21%Buy
View Top Biotech Stocks

Curevac Nv Stock Forecast FAQ

Is Curevac Nv Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CVAC) stock is to Hold CVAC stock.

Out of 3 analysts, 0 (0%) are recommending CVAC as a Strong Buy, 1 (33.33%) are recommending CVAC as a Buy, 2 (66.67%) are recommending CVAC as a Hold, 0 (0%) are recommending CVAC as a Sell, and 0 (0%) are recommending CVAC as a Strong Sell.

If you're new to stock investing, here's how to buy Curevac Nv stock.

What is CVAC's earnings growth forecast for 2025-2027?

(NASDAQ: CVAC) Curevac Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 25.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.35%.

Curevac Nv's earnings in 2025 is $225,160,465.On average, 8 Wall Street analysts forecast CVAC's earnings for 2025 to be -$115,979,587, with the lowest CVAC earnings forecast at -$163,285,569, and the highest CVAC earnings forecast at -$28,370,080. On average, 8 Wall Street analysts forecast CVAC's earnings for 2026 to be -$112,151,878, with the lowest CVAC earnings forecast at -$174,318,378, and the highest CVAC earnings forecast at -$35,462,600.

In 2027, CVAC is forecast to generate -$21,817,942 in earnings, with the lowest earnings forecast at -$114,741,211 and the highest earnings forecast at $73,289,372.

What is CVAC's revenue growth forecast for 2025-2027?

(NASDAQ: CVAC) Curevac Nv's forecast annual revenue growth rate of -38.45% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 107.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.08%.

Curevac Nv's revenue in 2025 is $593,615,116.On average, 8 Wall Street analysts forecast CVAC's revenue for 2025 to be $13,672,802,257, with the lowest CVAC revenue forecast at $198,590,557, and the highest CVAC revenue forecast at $24,823,819,661. On average, 8 Wall Street analysts forecast CVAC's revenue for 2026 to be $16,872,091,632, with the lowest CVAC revenue forecast at $0, and the highest CVAC revenue forecast at $25,057,985,397.

In 2027, CVAC is forecast to generate $34,118,398,124 in revenue, with the lowest revenue forecast at $16,174,097,610 and the highest revenue forecast at $50,469,470,992.

What is CVAC's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CVAC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 107.15%.

What is CVAC's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CVAC price target, the average CVAC price target is $6.83, with the highest CVAC stock price forecast at $10.00 and the lowest CVAC stock price forecast at $5.00.

On average, Wall Street analysts predict that Curevac Nv's share price could reach $6.83 by Jun 26, 2026. The average Curevac Nv stock price prediction forecasts a potential upside of 27.48% from the current CVAC share price of $5.36.

What is CVAC's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CVAC) Curevac Nv's current Earnings Per Share (EPS) is $1.01. On average, analysts forecast that CVAC's EPS will be -$0.52 for 2025, with the lowest EPS forecast at -$0.73, and the highest EPS forecast at -$0.13. On average, analysts forecast that CVAC's EPS will be -$0.50 for 2026, with the lowest EPS forecast at -$0.77, and the highest EPS forecast at -$0.16. In 2027, CVAC's EPS is forecast to hit -$0.10 (min: -$0.51, max: $0.33).

What is CVAC's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CVAC) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.